162830105	162830105	CD	B-NP	O
|	|	NN	I-NP	O
MNH	MNH	NN	I-NP	O
|	|	NN	I-NP	O
45367796	45367796	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0066977	0066977	CD	B-NP	O
|	|	CC	I-NP	O
7/4/2003	7/4/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
STROKE	STROKE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/4/2003	7/4/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/26/2003	8/26/2003	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
AL	AL	NNP	B-NP	O
DAMIAN	DAMIAN	NNP	I-NP	O
DUMBAR	DUMBAR	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADMITTING	ADMITTING	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Stented	Stente	VBD	B-VP	O
basilar	basilar	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
,	,	,	O	O
Q-wave	Q-wave	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

OPERATIONS/PROCEDURES	OPERATIONS/PROCEDURES	NN	B-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
3/14/03	3/14/03	CD	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
AND	AND	CC	I-NP	O
REASON	REASON	NN	I-NP	O
FOR	FOR	NN	I-NP	O
HOSPITALIZATION	HOSPITALIZATION	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70-year-old	70-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
____	____	NN	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
managed	manage	VBD	B-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Maven	Maven	NNP	I-NP	O
Health	Health	NNP	I-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
complaining	complain	VBG	B-VP	O
of	of	IN	B-PP	O
lethargy	lethargy	NN	B-NP	O
,	,	,	I-NP	O
diplopia	diplopia	NN	I-NP	O
and	and	CC	I-NP	O
vertigo	vertigo	NN	I-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
information	information	NN	I-NP	O
regarding	regard	VBG	B-VP	O
her	her	PRP$	B-NP	O
symptomatology	symptomatology	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
currently	currently	RB	B-ADJP	O
available	available	JJ	I-ADJP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
initial	initial	JJ	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
poor	poor	JJ	I-ADJP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
glaucoma	glaucoma	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
abuse	abuse	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Not	Not	RB	B-ADJP	O
available	available	JJ	I-ADJP	O
currently	currently	RB	B-ADVP	O
in	in	IN	B-PP	O
detail	detail	NN	B-NP	O
but	but	CC	O	O
included	include	VBD	B-VP	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
ALLERGIES	ALLERGIES	NNPS	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
and	and	CC	I-NP	O
Diltiazem	Diltiazem	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
UPON	UPON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Revealed	Reveal	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
lethargic	lethargic	JJ	B-ADJP	O
,	,	,	O	O
obese	obese	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
face	face	NN	I-NP	O
is	be	VBZ	B-VP	O
slightly	slightly	RB	B-ADJP	O
asymmetric	asymmetric	JJ	I-ADJP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
left	left	JJ	I-NP	O
cheek	cheek	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
was	be	VBD	B-VP	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
extremities	extremity	NNS	I-NP	I-protein
had	have	VBD	B-VP	I-protein
1	1	CD	B-NP	I-protein
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
examination	examination	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
only	only	JJ	I-NP	O
focal	focal	JJ	I-NP	O
findings	finding	NNS	I-NP	O
were	be	VBD	B-VP	O
a	a	DT	B-NP	O
transient	transient	JJ	I-NP	O
skewed	skewed	JJ	I-NP	O
deviation	deviation	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
eyes	eye	NNS	I-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
information	information	NN	I-NP	O
regarding	regard	VBG	B-PP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
currently	currently	RB	B-ADJP	O
available	available	JJ	I-ADJP	O
.	.	.	O	O

Focal	Focal	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
and	and	CC	I-NP	O
numbness	numbness	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
delineated	delineate	VBN	I-VP	O
upon	upon	IN	B-PP	O
initial	initial	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

SUMMARY	SUMMARY	NN	B-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Neurology	Neurology	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
findings	finding	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
were	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
occlusion	occlusion	NN	I-NP	O
,	,	,	O	O
flat	flat	JJ	B-NP	O
high-grade	high-grade	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
basilar	basilar	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Neurology	Neurology	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neurologic	neurologic	JJ	I-NP	O
status	status	NN	I-NP	O
gradually	gradually	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
diplopia	diplopia	NN	B-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
awake	awake	RB	I-ADJP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
magnetic	magnetic	JJ	I-NP	O
resonance	resonance	NN	I-NP	O
imaging	imaging	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
10/21/03	10/21/03	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
left	left	JJ	I-NP	O
cerebellar	cerebellar	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
with	with	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
high-grade	high-grade	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
basilar	basilar	JJ	I-NP	O
artery	artery	NN	I-NP	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
appear	appear	VB	I-VP	O
a	a	DT	B-NP	O
bit	bit	NN	I-NP	O
more	more	JJR	B-NP	O
patent	patent	NN	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
scan	scan	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
10/20/03	10/20/03	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
transitioned	transitione	VBN	I-VP	O
from	from	IN	B-PP	O
heparin	heparin	NN	B-NP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
neurologically	neurologically	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

With	With	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
ruled	rule	VBD	B-VP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
positive	positive	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
markers	marker	NNS	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
peak	peak	JJ	I-NP	O
troponin-I	troponin-I	NN	I-NP	O
was	be	VBD	B-VP	O
11.02	11.02	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
peak	peak	JJ	I-NP	O
CKMB	CKMB	NN	I-NP	B-protein
was	be	VBD	B-VP	O
18.4	18.4	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
lateral	lateral	JJ	B-NP	O
T-wave	T-wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
new	new	JJ	I-VP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
old	old	JJ	I-NP	O
EKGs	EKG	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
laboratory	laboratory	NN	I-NP	O
where	where	WRB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
moderate	moderate	JJ	I-NP	O
stenoses	stenosis	NNS	I-NP	O
but	but	CC	B-PP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
high-grade	high-grade	JJ	I-NP	O
or	or	CC	I-NP	O
critical	critical	JJ	I-NP	O
stenoses	stenosis	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
however	however	RB	B-ADVP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
30	30	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
10/30/03	10/30/03	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
mildly	mildly	RB	I-NP	O
dilated	dilate	VBN	I-NP	O
left	left	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
to	to	TO	B-PP	O
51	51	CD	B-NP	O
mL	mL	NN	I-NP	O
of	of	IN	B-PP	O
mercury	mercury	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
moderate	moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	I-NP	O
elevated	elevated	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
relatively	relatively	RB	B-ADVP	O
aggressively	aggressively	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
high	high	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
beta-blockade	beta-blockade	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
and	and	CC	I-NP	O
CKMB	CKMB	NN	I-NP	B-protein
levels	level	NNS	I-NP	O
did	do	VBD	B-VP	O
decrease	decrease	VB	I-VP	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
weight	weight	NN	B-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
beta-blockade	beta-blockade	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
discussion	discussion	NN	I-NP	O
of	of	IN	B-PP	O
possibly	possibly	RB	B-ADVP	O
cardioverting	cardioverte	VBG	B-VP	O
her	her	PRP	B-NP	O
,	,	,	O	O
but	but	CC	O	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
this	this	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
deferred	defer	VBN	I-VP	O
.	.	.	O	O

With	With	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
management	management	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
managed	manage	VBN	I-VP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
with	with	IN	B-PP	O
hydralazine	hydralazine	NN	B-NP	O
and	and	CC	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
introduce	introduce	VB	I-VP	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
_____	_____	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
1.8-1	1.8-1	CD	I-NP	O
.9	.9	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
indicated	indicate	VBN	I-VP	O
at	at	IN	B-PP	O
some	some	DT	B-NP	O
point	point	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
near	near	JJ	I-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
Mitent	Mitent	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
PLANS	PLANS	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
see	see	VB	I-VP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Marco	Marco	NNP	B-NP	O
Kenouo	Kenouo	NNP	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Department	Department	NNP	I-NP	O
of	of	IN	B-PP	O
Medicine	Medicine	NNP	B-NP	O
on	on	IN	B-PP	O
9/26/04	9/26/04	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Doyle	Doyle	NNP	I-NP	O
Ghamdi	Ghamdi	NNP	I-NP	O
of	of	IN	B-PP	O
Neurology	Neurology	NNP	B-NP	O
on	on	IN	B-PP	O
2/12/03	2/12/03	CD	B-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Toney	Toney	NNP	I-NP	O
Montagna	Montagna	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Department	Department	NNP	I-NP	O
of	of	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
on	on	IN	B-PP	O
10/4/04	10/4/04	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
drip	drip	NN	I-NP	O
being	be	VBG	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
,	,	,	O	O
folic	folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Cosopt	Cosopt	NNP	B-NP	O
1	1	CD	I-NP	O
drop	drop	NN	I-NP	O
o.u.	o.u.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-6195237	1-6195237	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
GOODNIGHT	GOODNIGHT	NNP	B-NP	O
,	,	,	O	O
ZACHARY	ZACHARY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
NIEDZWIECKI	NIEDZWIECKI	NNP	B-NP	O
,	,	,	O	O
JEROME	JEROME	NNP	B-NP	O
WESTON	WESTON	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0448815	0448815	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/15/03	1/15/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/15/03	1/15/03	CD	B-NP	O

